List of insiders holdings for MADRIGAL PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | CxSynta LLC CAXTON CORP 10% Owner |
2015-11-20 19:00:14 | 28,991,306 0 |
28,991,306 | Form 13D |
| 2 | Kovner Bruce Director 10% Owner |
2015-12-08 14:09:10 | 3,092,677 18,019,580 |
21,112,257 | Form 4 |
| 3 | Chen Lin Huey 10% Owner |
2010-02-12 18:21:53 | 0 2,570,947 |
2,570,947 | Form 5/A |
| 4 | Bahcall Safi R President and CEO |
2014-02-13 16:25:26 | 1,853,135 580,000 |
2,433,135 | Form 5 |
| 5 | Chen Lan Bo Director |
2013-02-14 06:03:03 | 2,387,284 0 |
2,387,284 | Form 13G |
| 6 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
2024-06-27 17:03:44 | 0 1,799,251 |
1,799,251 | Form 4 |
| 7 | Taub Rebecca Pres., R&D, and CMO |
2025-03-07 17:00:27 | 468,425 655,540 |
1,123,965 | Form 4 |
| 8 | FRIEDMAN PAUL A Director |
2024-06-27 21:41:17 | 187,554 655,540 |
843,094 | Form 4 |
| 9 | WILSON ROBERT N Director |
2015-07-06 16:38:33 | 780,936 0 |
780,936 | Form 4 |
| 10 | BAY CITY CAPITAL LLC Bay City Capital Management IV LLC Bay City Capital Fund IV L.P. BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 10% Owner |
2023-12-13 16:05:57 | 567,644 0 |
567,644 | Form 13D |
| 11 | CRAVES FRED B Director |
2025-03-14 16:25:06 | 357,818 33,471 |
391,289 | Form 4 |
| 12 | Ramachandra Sumant President, R&D |
2013-03-13 17:53:37 | 300,000 0 |
300,000 | Form 4 |
| 13 | Bernitz Steven B SVP, Corporate Development |
2013-12-20 16:23:42 | 175,000 0 |
175,000 | Form 4 |
| 14 | Sibold William John President and CEO |
2025-03-07 17:47:56 | 139,378 0 |
139,378 | Form 4 |
| 15 | Vukovic Vojo SVP, Chief Medical Officer |
2015-10-06 17:33:43 | 132,300 0 |
132,300 | Form 4 |
| 16 | McMahon Arthur SVP, Human Resources |
2015-03-04 17:15:49 | 126,768 0 |
126,768 | Form 4 |
| 17 | Whitaker Anne Clem President and CEO |
2015-03-04 17:00:57 | 100,000 0 |
100,000 | Form 4 |
| 18 | Chadwick Jeremy G Sr. VP, Pgm Mgmt and Clin Ops |
2010-03-03 16:50:15 | 97,186 0 |
97,186 | Form 4 |
| 19 | REARDON WILLIAM S Director |
2015-07-06 16:34:50 | 69,392 0 |
69,392 | Form 4 |
| 20 | Ehrlich Keith S VP, Fin. and Admin., CFO |
2014-03-05 19:03:06 | 66,985 0 |
66,985 | Form 4 |
| 21 | Koya Keizo Sr. VP, Drug Development |
2012-03-08 20:20:33 | 63,036 0 |
63,036 | Form 4 |
| 22 | Jacobson Eric W Sr. VP, Research and CMO |
2009-04-14 16:51:45 | 47,112 0 |
47,112 | Form 4 |
| 23 | Barsoum James G Sr. VP, Research |
2009-04-14 16:46:10 | 42,900 0 |
42,900 | Form 4 |
| 24 | Williams Martin D Sr. VP, Business Dev., CBO |
2008-02-29 14:00:34 | 42,120 0 |
42,120 | Form 4 |
| 25 | Schor Chen Former President and CEO |
2016-07-22 17:23:27 | 37,178 0 |
37,178 | Form 4 |
| 26 | Schneebaum Marc R Chief Financial Officer |
2021-02-23 13:32:44 | 32,000 0 |
32,000 | Form 4 |
| 27 | Howarth Alex G. Chief Financial Officer |
2024-01-25 15:29:59 | 30,778 0 |
30,778 | Form 4 |
| 28 | BAILEY MICHAEL P Sr. VP, Chief Comm. Officer |
2010-08-06 16:41:58 | 29,627 0 |
29,627 | Form 4 |
| 29 | Lynch Brian Joseph SVP and General Counsel |
2024-01-25 15:24:30 | 26,813 530 |
27,343 | Form 4 |
| 30 | Levy Richard S Director |
2025-04-11 16:59:35 | 20,482 0 |
20,482 | Form 4 |
| 31 | KUFE DONALD W Director |
2015-07-06 16:32:21 | 20,000 0 |
20,000 | Form 4 |
| 32 | Morenstein Scott D Director |
2016-01-05 18:32:11 | 17,857 0 |
17,857 | Form 4 |
| 33 | Rieder Wendy E Former SVP, Gen. Counsel |
2016-07-22 17:18:07 | 17,730 0 |
17,730 | Form 4 |
| 34 | Huntsman Carole Chief Commercial Officer |
2025-03-07 16:31:44 | 17,693 0 |
17,693 | Form 4 |
| 35 | Kelley Shannon T General Counsel |
2025-03-07 16:50:46 | 15,845 0 |
15,845 | Form 4 |
| 36 | Singh Amar Sr. VP, Chief Business Officer |
2014-02-13 16:23:05 | 15,161 0 |
15,161 | Form 5 |
| 37 | Sukhija Remy Chief Commercial Officer |
2023-01-18 20:00:34 | 15,001 0 |
15,001 | Form 4 |
| 38 | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
2025-03-07 17:40:05 | 14,383 0 |
14,383 | Form 4 |
| 39 | Dier Mardi SVP and CFO |
2025-03-12 16:32:09 | 10,440 0 |
10,440 | Form 4 |
| 40 | MILLIGAN DAVID V Director |
2022-06-21 06:30:25 | 9,470 0 |
9,470 | Form 4 |
| 41 | Gollust Keith R Director |
2022-06-21 06:30:09 | 9,470 0 |
9,470 | Form 4 |
| 42 | Folkman Judah Director |
2007-07-03 08:47:10 | 7,676 0 |
7,676 | Form 4 |
| 43 | BATE KENNETH Director |
2025-02-28 16:30:17 | 7,382 0 |
7,382 | Form 4 |
| 44 | FOUSE JACQUALYN A Director |
2025-03-12 16:29:06 | 2,473 0 |
2,473 | Form 4 |
| 45 | Daly James M Director |
2025-02-28 16:31:10 | 1,912 0 |
1,912 | Form 4 |
| 46 | Cheong Raymond Director |
2023-06-20 06:19:37 | 0 0 |
0 | Form 3 |